$1.49 EPS Expected for Molina Healthcare, Inc. (MOH) This Quarter

Equities research analysts expect Molina Healthcare, Inc. (NYSE:MOH) to report $1.49 earnings per share for the current quarter, according to Zacks. Eight analysts have made estimates for Molina Healthcare’s earnings, with the highest EPS estimate coming in at $1.98 and the lowest estimate coming in at $1.29. Molina Healthcare reported earnings per share of $0.34 during the same quarter last year, which suggests a positive year over year growth rate of 338.2%. The business is scheduled to issue its next quarterly earnings results on Monday, February 11th.

According to Zacks, analysts expect that Molina Healthcare will report full year earnings of $9.25 per share for the current financial year, with EPS estimates ranging from $9.05 to $9.57. For the next year, analysts expect that the company will post earnings of $8.93 per share, with EPS estimates ranging from $7.05 to $9.65. Zacks’ earnings per share averages are an average based on a survey of research analysts that that provide coverage for Molina Healthcare.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, October 31st. The company reported $2.55 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.65 by $0.90. The business had revenue of $4.70 billion during the quarter, compared to analysts’ expectations of $4.72 billion. Molina Healthcare had a net margin of 1.27% and a return on equity of 30.50%. The company’s revenue for the quarter was down 6.6% on a year-over-year basis. During the same period in the previous year, the company earned ($1.62) EPS.

Several equities research analysts have recently issued reports on the stock. Zacks Investment Research raised shares of Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $155.00 price objective for the company in a research report on Tuesday, October 23rd. Jefferies Financial Group upgraded shares of Molina Healthcare from a “hold” rating to a “buy” rating and lifted their price target for the stock from $152.00 to $169.00 in a research note on Tuesday, November 13th. Piper Jaffray Companies lifted their price target on shares of Molina Healthcare to $165.00 and gave the stock an “overweight” rating in a research note on Wednesday, September 26th. ValuEngine lowered shares of Molina Healthcare from a “buy” rating to a “hold” rating in a research note on Thursday, November 1st. Finally, Morgan Stanley lifted their price target on shares of Molina Healthcare from $132.00 to $178.00 and gave the stock an “overweight” rating in a research note on Wednesday, September 5th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $131.92.

Shares of Molina Healthcare stock traded down $3.71 during trading on Friday, hitting $132.80. 550,404 shares of the stock were exchanged, compared to its average volume of 740,072. The stock has a market cap of $8.29 billion, a P/E ratio of 237.14, a price-to-earnings-growth ratio of 1.44 and a beta of 1.53. Molina Healthcare has a 12-month low of $71.07 and a 12-month high of $154.06. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 0.78.

In other Molina Healthcare news, Director Charles Z. Fedak sold 3,795 shares of Molina Healthcare stock in a transaction on Monday, November 19th. The shares were sold at an average price of $120.74, for a total value of $458,208.30. Following the transaction, the director now directly owns 18,464 shares in the company, valued at $2,229,343.36. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Dale B. Wolf sold 4,000 shares of Molina Healthcare stock in a transaction on Friday, November 9th. The shares were sold at an average price of $135.57, for a total transaction of $542,280.00. Following the completion of the transaction, the director now owns 10,214 shares in the company, valued at $1,384,711.98. The disclosure for this sale can be found here. Insiders have sold a total of 9,045 shares of company stock worth $1,172,076 over the last quarter. 0.65% of the stock is owned by company insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. increased its stake in Molina Healthcare by 14.0% in the third quarter. Vanguard Group Inc. now owns 5,773,626 shares of the company’s stock valued at $858,538,000 after purchasing an additional 709,776 shares during the period. Legal & General Group Plc increased its stake in Molina Healthcare by 13.5% in the third quarter. Legal & General Group Plc now owns 87,850 shares of the company’s stock valued at $13,063,000 after purchasing an additional 10,431 shares during the period. Kepos Capital LP acquired a new position in Molina Healthcare in the third quarter valued at $711,000. New Mexico Educational Retirement Board increased its stake in Molina Healthcare by 29.6% in the third quarter. New Mexico Educational Retirement Board now owns 14,430 shares of the company’s stock valued at $2,146,000 after purchasing an additional 3,300 shares during the period. Finally, TIAA CREF Investment Management LLC increased its stake in Molina Healthcare by 8.2% in the third quarter. TIAA CREF Investment Management LLC now owns 888,660 shares of the company’s stock valued at $132,144,000 after purchasing an additional 67,069 shares during the period.

About Molina Healthcare

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

See Also: Why investors pay attention to retained earnings

Get a free copy of the Zacks research report on Molina Healthcare (MOH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit